H Samaratunga

Summary

Affiliation: Sullivan Nicolaides Pathology
Country: Australia

Publications

  1. ncbi Significance of minute focus of adenocarcinoma on prostate needle biopsy
    Hemamali Samaratunga
    Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia
    Urology 70:299-302. 2007
  2. ncbi What is the molecular pathology of low-risk prostate cancer?
    Hemamali Samaratunga
    Department of Anatomical Pathology, Sullivan Nicolaides Pathology, 134 Whitmore Street, Taringa, Brisbane, QLD, 4068, Australia
    World J Urol 26:431-6. 2008
  3. ncbi Ductal adenocarcinoma of the prostate: current opinion and controversies
    Hemamali Samaratunga
    Sullivan Nicolaides Pathology, Brisbane, Australia
    Anal Quant Cytol Histol 30:237-46. 2008
  4. ncbi Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study
    H Samaratunga
    Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia
    Histopathology 45:55-64. 2004
  5. ncbi Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp
    Hemamali Samaratunga
    Sullivan Nicolaides Pathology, 134 Whitmore Street, Taringa, Brisbane, Queensland 4068, Australia
    Pathology 39:476-81. 2007
  6. ncbi Atypical prostatic glandular proliferations on needle biopsy: Diagnostic implications, use of immunohistochemistry, and clinical significance
    Hemamali Samaratunga
    Department of Anatomical Pathology, Sullivan Nicolaides Pathology, Royal Brisbane Hospital, University of Queensland, Brisbane, Queensland, Australia
    Anal Quant Cytol Histol 28:104-10. 2006
  7. ncbi Use of multiple biomarkers for a molecular diagnosis of prostate cancer
    Kelly A Landers
    Department of Surgery, Central Clinical Division, School of Medicine, University of Queensland, Herston, Queensland 4072, Australia
    Int J Cancer 114:950-6. 2005
  8. ncbi Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection
    H Samaratunga
    Anatomical Pathology, Royal Brisbane Hospital, QLD, Australia
    Pathology 33:532-5. 2001
  9. ncbi Phyllodes tumors of the breast: correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome
    H Samaratunga
    Department of Anatomical Pathology, Royal Brisbane Hospital, Queensland, Australia
    Pathol Int 51:866-73. 2001
  10. ncbi Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension
    Hemamali Samaratunga
    Aquesta Pathology, Brisbane, Queensland, 4064 Australia
    Hum Pathol 41:281-5. 2010

Collaborators

  • B Delahunt
  • Jonathan I Epstein
  • Peta Fairweather
  • Ian S Brown
  • Andrew J Ramsay
  • John D Hooper
  • Judith A Clements
  • Ying Dong
  • Aneel Kaushal
  • Melanie L Hunt
  • Robert A Gardiner
  • Kelly A Landers
  • Daniel R McCulloch
  • Matthew R Digby
  • Janet C Reid
  • MayLa Linn
  • Loan T Bui
  • John Lai
  • Mark N Adams
  • Olivia L Tan
  • Stephen A Myers
  • Michelle A Tebay
  • Betty Scells
  • David M Purdie
  • Martin F Lavin
  • Michelle J Burger
  • Dimitri M Odorico
  • Pascal Akl
  • Adrian C Herington

Detail Information

Publications15

  1. ncbi Significance of minute focus of adenocarcinoma on prostate needle biopsy
    Hemamali Samaratunga
    Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia
    Urology 70:299-302. 2007
    ..To assess the radical prostatectomy findings in patients with a minute focus of adenocarcinoma on prostate needle biopsy in current practice in Australia...
  2. ncbi What is the molecular pathology of low-risk prostate cancer?
    Hemamali Samaratunga
    Department of Anatomical Pathology, Sullivan Nicolaides Pathology, 134 Whitmore Street, Taringa, Brisbane, QLD, 4068, Australia
    World J Urol 26:431-6. 2008
    ..This review was to evaluate which of these changes may be useful to distinguish the group of patients likely to have significant carcinoma within the low risk category...
  3. ncbi Ductal adenocarcinoma of the prostate: current opinion and controversies
    Hemamali Samaratunga
    Sullivan Nicolaides Pathology, Brisbane, Australia
    Anal Quant Cytol Histol 30:237-46. 2008
    ..To evaluate the morphologic spectrum and clinical significance of ductal adenocarcinoma of the prostate (DAP)...
  4. ncbi Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study
    H Samaratunga
    Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia
    Histopathology 45:55-64. 2004
    ..To investigate whether prognosis in micropapillary urothelial carcinoma is related to the proportion of the micropapillary component (MPC), and to identify the immunohistochemical features of MPC...
  5. ncbi Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp
    Hemamali Samaratunga
    Sullivan Nicolaides Pathology, 134 Whitmore Street, Taringa, Brisbane, Queensland 4068, Australia
    Pathology 39:476-81. 2007
    ..Centrally located prostatic ductal adenocarcinoma can present as a single urethral polyp mimicking a benign polyp. Such lesions have not been formally studied...
  6. ncbi Atypical prostatic glandular proliferations on needle biopsy: Diagnostic implications, use of immunohistochemistry, and clinical significance
    Hemamali Samaratunga
    Department of Anatomical Pathology, Sullivan Nicolaides Pathology, Royal Brisbane Hospital, University of Queensland, Brisbane, Queensland, Australia
    Anal Quant Cytol Histol 28:104-10. 2006
    ..Patients with atypical glands on prostate needle biopsy have a high risk for harboring cancer and therefore have an increased risk for having cancer detected in subsequent biopsies...
  7. ncbi Use of multiple biomarkers for a molecular diagnosis of prostate cancer
    Kelly A Landers
    Department of Surgery, Central Clinical Division, School of Medicine, University of Queensland, Herston, Queensland 4072, Australia
    Int J Cancer 114:950-6. 2005
    ..Supplemental material for this article can be found on the International Journal of Cancer website at http://www.interscience.wiley.com/jpages/0020-7136/suppmat/index.html.)..
  8. ncbi Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection
    H Samaratunga
    Anatomical Pathology, Royal Brisbane Hospital, QLD, Australia
    Pathology 33:532-5. 2001
    ..Viral culture or PCR may need to be performed for a definite diagnosis to alleviate prolonged discomfort and avoid unnecessary radical surgery...
  9. ncbi Phyllodes tumors of the breast: correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome
    H Samaratunga
    Department of Anatomical Pathology, Royal Brisbane Hospital, Queensland, Australia
    Pathol Int 51:866-73. 2001
    ..Ag-NOR counts are significant in predicting survival in the presence of histopathological features of malignancy...
  10. ncbi Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension
    Hemamali Samaratunga
    Aquesta Pathology, Brisbane, Queensland, 4064 Australia
    Hum Pathol 41:281-5. 2010
    ..In view of the significant association with extraprostatic extension we would recommend that in both core biopsies and radical prostatectomy specimens any proportion of ductal adenocarcinoma of the prostate should be reported...
  11. ncbi Significance of stromal reaction patterns in invasive urothelial carcinoma
    Hemamali Samaratunga
    Department of Surgical Pathology, Sullivan Nicolaides, Pathology, Brisbane, Australia
    Am J Clin Pathol 123:851-7. 2005
    ..Stromal reaction patterns seem to have some prognostic usefulness. Cases with stromal edema might benefit from closer follow-up. Awareness of the different types of stromal reactions also is useful for diagnosing invasion...
  12. ncbi Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP
    Daniel R McCulloch
    Hormone-Dependent Cancer Program, School of Life Sciences, Queensland University of Technology, Brisbane, Queensland, Australia
    Clin Cancer Res 10:314-23. 2004
    ..The regulation and membrane localization of ADAM-10 support our hypothesis that ADAM-10 has a role in extracellular matrix maintenance and cell invasion, although the potential role of nuclear ADAM-10 is not yet known...
  13. ncbi A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus
    Aneel Kaushal
    Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Australia
    Prostate 68:381-99. 2008
    ..Other members of the KLK family are also emerging as potential adjunct biomarkers for this disease. Our aim was to identify and characterize novel KLK-related genes with potential as PCa bio-markers...
  14. ncbi Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression
    Andrew J Ramsay
    Institute of Health and Biomedical Innovation and School of Life Sciences, Queensland University of Technology, Corner Musk Ave and Blamey St, Kelvin Grove, Queensland 4059, Australia
    J Biol Chem 283:12293-304. 2008
    ..These data provide insight into KLK4-mediated cell signaling and suggest that signals induced by this enzyme via PARs may be important in prostate cancer...
  15. ncbi Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)
    Andrew J Ramsay
    Institute of Health and Biomedical Innovation, Queensland University of Technology, 6 Musk Avenue, Kelvin Grove, Queensland 4059, Australia
    Biol Chem 389:653-68. 2008
    ....